• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

GRN No. 43

Substance: Lipase derived from Aspergillus oryzae carrying a gene encoding lipase from Thermomyces lanuginosus
Intended Use: Use in dough, baked goods, and the fats and oil industry as a processing aid for the interesterification or hydrolysis of glycerides at minimum levels necessary to achieve the desired effect; use as an enzyme in brewing beer (per additional correspondence of April 21, 2010)
Basis: Scientific procedures
Notifier: Novo Nordisk
77 Perry Chapel Church Road; Box 576; Franklinton, NC 27525
Date of filing: Apr 28, 2000
GRAS Notice (releasable information): 43
Date of closure / FDA's Letter: Sep 22, 2000
FDA has no questions (additional correspondence available)
Additional correspondence: Additional correspondence about intended use: April 21, 2010
-
-